None listed
Conditions
Brief summary
The purpose of this study is to evaluate patient satisfaction and experiences of Mandarin-speaking patients with the use of a translation device during radiation therapy. Who is it for? You may be eligible for this study if you are aged 18 years or older, speak Mandarin at home, and will be receiving cancer radiation therapy for 5 days or more. Study details All participants in this study will first do questionnaires on English literacy and health literacy. Afterwards, for the duration of their radiotherapy treatment, participants will be instructed to use the digital translation device during radiotherapy positioning and any discussions with radiotherapy staff. After the trial is over, there will be a paper based post treatment survey to ask each participant about their satisfaction with their experiences. It is hoped that this research will allow Mandarin-speaking patients and radiation therapists to communicate more effectively, thus improving disease management and patient experience for culturally and linguistically diverse patients.
Interventions
An instant translation device (ITD) will be utilised by consenting Mandarin speaking patients when they present for daily radiotherapy treatment.
At present there is an expanding market for ITDs spanning the Logbar Ili, Google Pixel Buds, The Pilot and Travis the Translator to name a few. Whilst many current ITDs are limited to one-way communication, WiFi reliance, or in-ear insertion, Travis the Translator provides a robust and appropriate design for use in a clinical environment. The first pro
An instant translation device (ITD) will be utilised by consenting Mandarin speaking patients when they present for daily radiotherapy treatment. At present there is an expanding market for ITDs spanning the Logbar Ili, Google Pixel Buds, The Pilot and Travis the Translator to name a few. Whilst many current ITDs are limited to one-way communication, WiFi reliance, or in-ear insertion, Travis the Translator provides a robust and appropriate design for use in a clinical environment. The first prototype of Travis the Translator (Travis One) was completed in February 2017, and shipped from September 2017. To date, the Rotterdam-based group have in excess of 50,000 users across 100 countries. Travis the Translator offers one-touch ease of use, interpreting up to 80 languages online and 23 languages offline within two seconds of acquisition. The ITD will not replace the use of the interpreter at Computer Tomography (CT) simulation, fraction 1, or subsequent nursing/Radiation Oncology (RO)/Allied Health (AH)consultations, but rather facilitate all other daily radiation therapy interactions between Radiation Therapists (RT) and patient, including before and during patient positioning and after radiotherapy session completed. The ITDs are physical devices and are supplied by Peter MacCallum Cancer Centre to Liverpool and Macarthur Cancer Therapy Centres. Radiotherapy staff will be trained to operate ITD for participants, and will be in charge of maintaining and storing device. ITDs are not accessible by participants. Participants will be utilising ITD for daily radiotherapy set up and discussions, this is dependent on the number of fractions prescribed by the RO and will differ between individual participants depending on their treatment schedule. Participants receiving less than 5 days of treatment are excluded from trial. A log sheet will be kept to detail the amount of times ITD is used. Participants use the device by speaking Mandarin into the device, which has an inbuilt microphone and is operated by staff, and the device will translate to English via an inbuilt speaker. Staff will use the device by speaking English into the device for it to be translated into Mandarin. There is no use of headphones. Treatment Fraction 1: Participant to undergo standard Radiation Therapy information session with interpreter. Participant to be provided with ITD training and familiarisation. Daily log sheet to be completed by RTs Subsequent Treatment Fractions: Participant to utilise ITD for daily setup, and discussion with RT staff. Daily log sheet to be completed by RTs. Final Treatment Fraction: Participant to complete a satisfaction and experience survey as assisted by an interpreter present at the final nursing review. Trial coordinator to liaise with site lead to complete the end of treatment summary When a patient withdraws from the study, the reasons for withdrawal shall be recorded by the investigator on the relevant page of the log sheet. Whenever possible, all patients who withdraw from the study prematurely will confirm permission to retain the data provided thus far. Patients who fail to return for radiation treatment will be followed up by the treating radiation therapists as part of standard care.
Sponsors
Monash University Graduate Research Office
Study design
Allocation
Non-randomised trial
Intervention model
Single group
Primary purpose
Treatment
Masking
Open (masking not used)
Eligibility
Sex/Gender
All
Age
18 Years to No maximum
Healthy volunteers
No
Inclusion criteria
The patient is 18 years of age or older. The patient is diagnosed with cancer and has been referred for radiation therapy. The patient is planned to receive radiation therapy for a period of 5 days or more. The patient self-reports Mandarin as the primary language spoken at home. The patient self-reports a basic level of Mandarin literacy.
Exclusion criteria
The patient has not previously received radiation therapy. The patient has no known functional or cognitive impairment that would limit their ability to utilise the device and or formulate a response.
Outcome results
None listed